eight insulin-dependent diabetic patients received constant iv infusions of biosynthetic human c-peptide which raised the plasma c-peptide concentration to a level of 3.8 +/- 0.2 ( +/- sem ) pmol/ml .
C0086418
human
C0006558
c-peptide